The new treatment offers hope to thousands living with advanced urothelial cancer, with clinical trials showing overall survival rates were almost twice as long compared to standard treatment.
Millions of people are set to benefit from earlier access to newer type 2 diabetes treatments – the biggest shake-up in care for a decade – as part of NICE’s commitment to re-evaluate priority clinical pathways described in the 10-Year Health Plan for the NHS.
Recommendations in NICE’s type 2 diabetes guideline update published today will enhance the use of SGLT-2 inhibitors in primary care and address these health inequalities.
People with heart disease will be able to do their recovery sessions from home rather than travelling for rehabilitation appointments after our independent committee conditionally recommended 6 digital platforms for use in the NHS.
Our annual report and accounts summarise our key achievements from April 2024 to March 2025.
NICE International has helped Egypt take a crucial step towards a fairer, more efficient healthcare system.
How NICE International is supporting evidence-based decision-making through the Regulatory Partnership for Growth Fund
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
